Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro pen prices in the UK private market have shifted significantly since Eli Lilly raised its list price from 1 September 2025, with typical private costs now ranging roughly £149 to £375 per month depending on the dose and provider. That figure tells you part of the story. What it often leaves out is whether a clinical assessment, a prescription, delivery and any follow-up support are included — and for a prescription-only medicine, those aren't optional extras. Mounjaro (tirzepatide) is a POM, meaning a prescriber must assess your suitability before any pen is dispensed, regardless of where you buy.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture the moment most people are in when they search this: you've done some reading, you think Mounjaro might suit you, and you're now looking at a range of monthly figures wondering why they vary so much. Some prices sit near £150. Others are closer to £350. A few look suspiciously low.
The honest answer is that the headline figure tells you almost nothing on its own. After Eli Lilly adjusted its UK list pricing on 1 September 2025, the highest dose moved from around £122 to around £330 per four-week pen as a list price, a significant jump that rippled through private providers at different speeds and in different ways. Reported market prices since then sit roughly in the £149–£375 range by dose and provider, though these figures shift. The full picture of what drives Mounjaro pricing is worth reading before you make any assumptions about value.
Lower doses, particularly the 2.5mg starter pen, tend to sit at the lower end. That pen exists to help your system adjust, not as a long-term dose, so the price of beginning treatment and the price of maintaining it are different conversations. If you want to understand what the 2.5mg pen costs and what it's for, that page goes into the detail. Similarly, if you're moving up the dose schedule, you can read about what the 5mg Mounjaro pen costs at this stage of treatment to understand where that step sits financially, and for a focused breakdown of that particular pen, the Mounjaro 5mg pen price page covers exactly what you'd expect to pay and why.
The variation between providers often comes down to what surrounds the pen, not the pen itself.
A number of services list a per-pen price and add consultation fees, prescription charges or delivery costs separately. Some charge for dose-increase reviews. A few add subscription fees that auto-renew even when you haven't explicitly re-ordered. None of that is inherently wrong, but it does mean two prices that look similar on paper can represent very different actual costs by month three.
The things worth checking before committing to any provider: Is there a separate consultation fee? Is the prescription included, or is it a surcharge? What does delivery cost, and is it tracked? Is aftercare (the support you'd want if nausea hits in week two) available, and is it free? Does the service require a subscription, or can you order as and when you need to? Our FAQs set out exactly how the process works at nume, if a direct comparison helps.
One misconception worth naming gently: some people assume that a lower monthly figure means the clinical oversight is the same, that it's just a price difference, like choosing between supermarkets. With a prescription medicine it isn't. The clinical review is the product, as much as the pen is. You're not buying a commodity; you're entering a supervised medical programme, and the quality of that supervision varies. Our clinical team can tell you more about how that review is structured.
We are not the cheapest option in the UK private market. That's a deliberate choice. One transparent price covers your consultation, your prescription, your treatment, free next-working-day DPD delivery and 7-day aftercare, with no subscription, no auto-renewal and a clinical re-review before every repeat. The current treatment price is on our treatment page; we don't print per-pen figures in body copy because they change and because a pen without everything around it isn't what we're offering.
There are no discount codes, no seasonal sales, no vouchers. If you've seen a code being promoted for Mounjaro from any online source, that's worth treating with caution, we explain why on our Mounjaro pen price page, along with the MHRA's warnings about counterfeit pens entering the UK market through unverified sellers. For anyone considering Mounjaro for weight management more broadly, the licensing, eligibility and evidence are all covered there.
The MHRA has been clear that GLP-1 medicines for weight loss should be obtained through legitimate, clinically supervised routes. Counterfeit pens have been seized across the UK; some contained the wrong substance entirely. The safe route is a pharmacy you can verify on the GPhC register, ours is registered under number 9012878, verifiable directly on the GPhC register. Medicines sourced through unverified sellers (offered without a clinical assessment, through social media, or at prices well below the market) carry risks that a small saving doesn't offset.
For a prescription-only medicine, the right question isn't which provider is cheapest. It's which provider gives you a genuine clinical assessment, a licensed supply chain, and support if something unexpected happens. That's what the price is for. If you'd like to speak to our prescribers about whether Mounjaro is clinically right for you, start your free consultation here, reviewed the same day, dispatched once approved.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.